Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells - PubMed

Affiliations

• PMID: 16123384
• DOI: 10.1634/stemcells.2005-0008

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells

Mauro Krampera et al. Stem Cells. 2006 Feb.

Abstract

Mesenchymal stem cells (MSCs) inhibit the proliferation of HLA-unrelated T lymphocytes to allogeneic stimulation, but the mechanisms responsible for this activity are not fully understood. We show here that MSCs suppress the proliferation of both CD4+ and CD8+ T lymphocytes, as well as of natural killer (NK) cells, whereas they do not have an effect on the proliferation of B lymphocytes. The antiproliferative effect of MSCs was not associated with any effect on the expression of cell-activation markers, induction of cell apoptosis, or mimicry/enhancement of T regulatory cell activity. The suppressive activity of MSCs was not contact-dependent and required the presence of interferon (IFN)-gamma produced by activated T cells and NK cells. Accordingly, even activated B cells became susceptible to the suppressive activity of MSCs in the presence of exogenously added IFN-gamma. The suppressive effect of IFN-gamma was related to its ability to stimulate the production by MSCs of indoleamine 2,3-dioxygenase activity, which in turn inhibited the proliferation of activated T or NK cells. These findings suggest that the beneficial effect on graft-versus-host disease induced by in vivo coinfusion with the graft of MSCs may be due to the activation of the immunomodulatory properties of MSCs by T cell- derived IFN-gamma.

Similar articles

• Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.

  Zheng ZH, Li XY, Ding J, Jia JF, Zhu P. Zheng ZH, et al. Rheumatology (Oxford). 2008 Jan;47(1):22-30. doi: 10.1093/rheumatology/kem284. Rheumatology (Oxford). 2008. PMID: 18077486

• Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.

  DelaRosa O, Lombardo E, Beraza A, Mancheño-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, García L, Abad JL, Trigueros C, Delgado M, Büscher D. DelaRosa O, et al. Tissue Eng Part A. 2009 Oct;15(10):2795-806. doi: 10.1089/ten.TEA.2008.0630. Tissue Eng Part A. 2009. PMID: 19231921

• Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.

  Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, Sung KW, Kim CW, Koo HH. Yoo KH, et al. Cell Immunol. 2009;259(2):150-6. doi: 10.1016/j.cellimm.2009.06.010. Epub 2009 Jun 23. Cell Immunol. 2009. PMID: 19608159

• Immune plasticity of bone marrow-derived mesenchymal stromal cells.

  Stagg J, Galipeau J. Stagg J, et al. Handb Exp Pharmacol. 2007;(180):45-66. doi: 10.1007/978-3-540-68976-8_3. Handb Exp Pharmacol. 2007. PMID: 17554504 Review.

• Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

  Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Gattoni A, et al. Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. PMID: 17051976 Retracted. Review.

Cited by

• Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.

  Al-Khawaga S, Abdelalim EM. Al-Khawaga S, et al. Stem Cell Res Ther. 2020 Oct 15;11(1):437. doi: 10.1186/s13287-020-01963-6. Stem Cell Res Ther. 2020. PMID: 33059757 Free PMC article. Review.

• Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

  Diehl R, Ferrara F, Müller C, Dreyer AY, McLeod DD, Fricke S, Boltze J. Diehl R, et al. Cell Mol Immunol. 2017 Feb;14(2):146-179. doi: 10.1038/cmi.2016.39. Epub 2016 Oct 10. Cell Mol Immunol. 2017. PMID: 27721455 Free PMC article. Review.

• Galectin-9 Mediates the Therapeutic Effect of Mesenchymal Stem Cells on Experimental Endotoxemia.

  Zhao Y, Yu D, Wang H, Jin W, Li X, Hu Y, Qin Y, Kong D, Li G, Ellen A, Wang H. Zhao Y, et al. Front Cell Dev Biol. 2022 Feb 17;10:700702. doi: 10.3389/fcell.2022.700702. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252164 Free PMC article.

• Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases.

  da Costa Gonçalves F, Paz AH. da Costa Gonçalves F, et al. World J Stem Cells. 2019 Sep 26;11(9):618-633. doi: 10.4252/wjsc.v11.i9.618. World J Stem Cells. 2019. PMID: 31616539 Free PMC article. Review.

• Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

  Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D. Ghannam S, et al. Stem Cell Res Ther. 2010 Mar 15;1(1):2. doi: 10.1186/scrt2. Stem Cell Res Ther. 2010. PMID: 20504283 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program